Something for Everyone

Article

Attendees at the ONS Congress are still energized on the start of day three of the conference. Today’s sessions covered a wide range of topics ranging from long-term care of breast cancer survivors to treatment of metastatic disease.

Attendees at the ONS Congress are still energized on the start of day three of the conference. The 6:00 AM educational breakfasts are well attended and traffic in the exhibit area remains high-paced. Marilyn Haas delivered the annual Bench to Bedside lecture on advancements in radiation therapy. The technological advancements have made this treatment modality more targeted in its delivery and consequently safer and more effective.

Today’s sessions covered a wide range of topics ranging from long-term care of breast cancer survivors to treatment of metastatic disease. A workshop on financial planning was sponsored by the ONS Foundation. Pain management continues to be a topic of interest. In addition to clinical topics, there are sessions geared to self-care, such as the session on Healing the Healer within You. The Congress Planning Team has ensured that there is “something for everyone” attending this conference.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.